No Data
$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
Standard BioTools Second Quarter 2024 Earnings: Misses Expectations
Standard BioTools | 10-Q: Q2 2024 Earnings Report
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (NASDAQ:LAB) Analysts Just Slashed This Year's Revenue Estimates By 15%
Standard BioTools Inc. (NASDAQ:LAB) Just Reported And Analysts Have Been Cutting Their Estimates